🇺🇸 FDA
Pipeline program

mitomycin C

CAO-NO.201402024-benign

Unknown small_molecule active

Quick answer

mitomycin C for Obstructive Airway Disease is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Obstructive Airway Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials